Patrick Gallagher
Founder chez Cingulate Therapeutics LLC
Fortune : 12 917 $ au 31/03/2024
Profil
Patrick Joseph Gallagher is the founder of Cingulate Therapeutics LLC, which was founded in 2013.
He is currently the Chief Executive Officer & Director at Voltron Therapeutics, Inc., Chief Executive Officer & Director at PD Theranostics, Inc., Independent Director at Cingulate Works, Inc., Senior MD & Head-Healthcare Sales at Laidlaw & Co. (UK) Ltd., Managing Partner at Laidlaw Private Equity LLC, and Treasurer at Aerwave Medical, Inc. Mr. Gallagher's former jobs include Chief Executive Officer & Partner at BDR Research LLC, Independent Director at BioSig Technologies, Inc. from 2014 to 2024, Director-Institutional Sales at New Vernon Associates, Inc., Managing Director at Potomac Management Group, Inc., Director at Protea Biosciences Group, Inc., Director at Algorithm Sciences, Inc., Independent Director at Cingulate, Inc. from 2014 to 2023, VP-Business Development & Investor Relations at Athenex, Inc. from 2012 to 2013, Principal at PaineWebber, Inc., Principal at Kidder, Peabody & Co., Inc., and Senior Vice President at Cowen Prime Services LLC from 2010 to 2011.
Mr. Gallagher received an MBA degree from The Pennsylvania State University in 1993 and an undergraduate degree from the University of Vermont in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/11/2023 | 13 854 ( 0,15% ) | 9 157 $ | 31/03/2024 | |
CINGULATE, INC.
0,09% | 12/09/2023 | 3 418 ( 0,09% ) | 3 760 $ | 31/03/2024 |
Postes actifs de Patrick Gallagher
| Sociétés | Poste | Début |
|---|---|---|
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 01/09/2014 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Founder | 01/07/2013 |
Laidlaw Private Equity, LLC
 Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Private Equity LLC (Laidlaw Private Equity) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd founded by James Ahern. The firm is headquartered in New York. | Private Equity Investor | 01/06/2019 |
Pd Theranostics, Inc.
 Pd Theranostics, Inc. Packaged SoftwareTechnology Services Pd Theranostics, Inc. develops algorithms for prostate cancer and diabetic foot ulcers patience. The company is headquartered in New York, NY. | Chief Executive Officer | 01/09/2017 |
Voltron Therapeutics, Inc.
 Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY. | Chief Executive Officer | 01/01/2018 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Director/Board Member | 01/01/2014 |
Aerwave Medical, Inc.
 Aerwave Medical, Inc. Medical/Nursing ServicesHealth Services Aerwave Medical, Inc. is a company that is developing a unique alternative to traditional medications used to treat pulmonary diseases such as asthma and COPD. The company is based in New York, NY, and the CEO of the company is Jeffrey Francis O'Donnell. These diseases are characterized by an unmet medical need, with up to 15% of asthma patients and 25% of COPD patients being unresponsive to treatment. Additionally, around 50% of long-term inhaler users discontinue use within the first year due to compliance issues and multiple side effects. Aerwave Medical's revolutionary approach involves an interventional method to treat these diseases. | Treasurer | 01/11/2020 |
Anciens postes connus de Patrick Gallagher
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSIG TECHNOLOGIES, INC. | Director/Board Member | 19/02/2024 |
| CINGULATE INC. | Director/Board Member | 12/12/2023 |
| ░░░░░░░░░░ | ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Patrick Gallagher
| The Pennsylvania State University | Masters Business Admin |
| University of Vermont | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOSIG TECHNOLOGIES, INC. | Health Technology |
| CINGULATE INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
| PaineWebber, Inc. | Finance |
New Vernon Associates, Inc.
 New Vernon Associates, Inc. Investment ManagersFinance Founded in 1992 by Paul Christopherson, New Vernon Associates, Inc. is an independent investment research firm and SEC-registered broker/dealer located in Parsippany, New Jersey. The firm is affiliated with private equity firm New Vernon Capital LLC. New Vernon Associates provides services exclusively to institutional investors. Their research coverage focuses primarily on the chemicals, biotechnology and pharmaceutical sectors. | Finance |
Potomac Management Group, Inc.
 Potomac Management Group, Inc. Miscellaneous Commercial ServicesCommercial Services Potomac Management Group, Inc. provides safety consulting services. It offers information technology, maritime consulting, program/project management and multimedia services to clients in the government sector. The company was founded in 1992 and is headquartered in Alexandria, VA. | Commercial Services |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
BDR Research LLC
 BDR Research LLC Investment ManagersFinance Founded in 2001, BDR Research LLC is an independent investment research firm headquartered in New York City. The firm focuses on healthcare, biotechnology, large-cap pharmaceuticals, specialty chemicals and materials, commodity chemicals, machinery companies | Finance |
Kidder, Peabody & Co., Inc.
 Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Finance |
Cowen Prime Services LLC
 Cowen Prime Services LLC Investment Banks/BrokersFinance Cowen Prime Services LLC (CPS) is a broker-dealer headquartered in New York City. The firm is directly owned by Cowen PB Holdings LLC, which, in turn, is primarily owned by Cowen Group, Inc. (NASDAQ: COWN). CPS is registered as a broker-dealer with the SEC and FINRA, and as a an introducing broker with the Commodities Futures Trading Commission and the National Futures Association. CPS was formed in 2015 following Cowen Group’s acquisition of Concept Capital Markets LLC. Concept Capital was established in 2010 following the spin-off of the Concept Capital division of Sanders Morris Harris Inc., whose origins date back to 1995. CPS' offering includes world-class custody and clearing options, multi asset class capabilities, leading execution and order management systems, a seasoned execution desk, a range of financing options, a highly professional operations and customer support team, comprehensive portfolio reporting capabilities, capital introduction, and live, intraday and post-trade risk and performance analytics. | Finance |
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
Algorithm Sciences, Inc.
 Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY. | Health Technology |
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Private Equity LLC (Laidlaw Private Equity) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd founded by James Ahern. The firm is headquartered in New York. | Finance |
Pd Theranostics, Inc.
Pd Theranostics, Inc. Packaged SoftwareTechnology Services Pd Theranostics, Inc. develops algorithms for prostate cancer and diabetic foot ulcers patience. The company is headquartered in New York, NY. | Technology Services |
Aerwave Medical, Inc.
Aerwave Medical, Inc. Medical/Nursing ServicesHealth Services Aerwave Medical, Inc. is a company that is developing a unique alternative to traditional medications used to treat pulmonary diseases such as asthma and COPD. The company is based in New York, NY, and the CEO of the company is Jeffrey Francis O'Donnell. These diseases are characterized by an unmet medical need, with up to 15% of asthma patients and 25% of COPD patients being unresponsive to treatment. Additionally, around 50% of long-term inhaler users discontinue use within the first year due to compliance issues and multiple side effects. Aerwave Medical's revolutionary approach involves an interventional method to treat these diseases. | Health Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
